Apoferritin-encapsulated jerantinine A for transferrin receptor targeting and enhanced selectivity in breast cancer therapy
The O-acetyl (or acetate) derivative of the Aspidosperma alkaloid Jerantinine A (JAa) elicits anti-tumor activity against cancer cell lines including mammary carcinoma cell lines irrespective of receptor status (0.14 < GI50 < 0.38 mu M), targeting microtubule dynamics. By exploiting breast can...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Published: |
American Chemical Society
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/41924/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.41924 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.419242023-10-23T08:55:25Z http://eprints.um.edu.my/41924/ Apoferritin-encapsulated jerantinine A for transferrin receptor targeting and enhanced selectivity in breast cancer therapy Abuzaid, Haneen Abdelrazig, Salah Ferreira, Lenny Collins, Hilary M. Kim, Dong-Hyun Lim, Kuan-Hon Kam, Toh-Seok Turyanska, Lyudmila Bradshaw, Tracey D. RC Internal medicine The O-acetyl (or acetate) derivative of the Aspidosperma alkaloid Jerantinine A (JAa) elicits anti-tumor activity against cancer cell lines including mammary carcinoma cell lines irrespective of receptor status (0.14 < GI50 < 0.38 mu M), targeting microtubule dynamics. By exploiting breast cancer cells' upregulated transferrin receptor 1 (TfR1) expression and apoferritin (AFt) recognition, we sought to develop an AFt JAa-delivery vehicle to enhance tumor-targeting and reduce systemic toxicity. Optimizing pH-mediated reassembly, similar to 120 JAa molecules were entrapped within AFt. Western blot and flow cytometry demonstrate TfR1 expression in cancer cells. Enhanced internalization of 5-carboxyfluorescein-conjugated human AFt in SKBR3 and MDA-MB-231 cancer cells is observed compared to MRC5 fibroblasts. Accordingly, AFt-JAa delivers significantly greater intracellular JAa levels to SKBR3 and MDAMB-231 cells than naked JAa (0.2 mu M) treatment alone. Compared to naked JAa (0.2 mu M), AFt-JAa achieves enhanced growth inhibition (2.5-14-fold; <0.02 mu M < GI50 < 0.15 mu M) in breast cancer cells; AFt-JAa treatment results in significantly reduced clonal survival, more profound cell cycle perturbation including G2/M arrest, greater reduction in cell numbers, and increased apoptosis compared to the naked agent (p < 0.01). Decreased PLK1 and Mcl-1 expression, together with the appearance of cleaved poly (ADP-ribose)polymerase, corroborate the augmented potency of AFt-JAa. Hence, we demonstrate that AFt represents a biocompatible vehicle for targeted delivery of JAa, offering potential to minimize toxicity and enhance JAa activity in TfR1-expressing tumors. American Chemical Society 2022-06 Article PeerReviewed Abuzaid, Haneen and Abdelrazig, Salah and Ferreira, Lenny and Collins, Hilary M. and Kim, Dong-Hyun and Lim, Kuan-Hon and Kam, Toh-Seok and Turyanska, Lyudmila and Bradshaw, Tracey D. (2022) Apoferritin-encapsulated jerantinine A for transferrin receptor targeting and enhanced selectivity in breast cancer therapy. ACS Omega, 7 (25). pp. 21473-21482. ISSN 2470-1343, DOI https://doi.org/10.1021/acsomega.2c00997 <https://doi.org/10.1021/acsomega.2c00997>. 10.1021/acsomega.2c00997 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
RC Internal medicine |
spellingShingle |
RC Internal medicine Abuzaid, Haneen Abdelrazig, Salah Ferreira, Lenny Collins, Hilary M. Kim, Dong-Hyun Lim, Kuan-Hon Kam, Toh-Seok Turyanska, Lyudmila Bradshaw, Tracey D. Apoferritin-encapsulated jerantinine A for transferrin receptor targeting and enhanced selectivity in breast cancer therapy |
description |
The O-acetyl (or acetate) derivative of the Aspidosperma alkaloid Jerantinine A (JAa) elicits anti-tumor activity against cancer cell lines including mammary carcinoma cell lines irrespective of receptor status (0.14 < GI50 < 0.38 mu M), targeting microtubule dynamics. By exploiting breast cancer cells' upregulated transferrin receptor 1 (TfR1) expression and apoferritin (AFt) recognition, we sought to develop an AFt JAa-delivery vehicle to enhance tumor-targeting and reduce systemic toxicity. Optimizing pH-mediated reassembly, similar to 120 JAa molecules were entrapped within AFt. Western blot and flow cytometry demonstrate TfR1 expression in cancer cells. Enhanced internalization of 5-carboxyfluorescein-conjugated human AFt in SKBR3 and MDA-MB-231 cancer cells is observed compared to MRC5 fibroblasts. Accordingly, AFt-JAa delivers significantly greater intracellular JAa levels to SKBR3 and MDAMB-231 cells than naked JAa (0.2 mu M) treatment alone. Compared to naked JAa (0.2 mu M), AFt-JAa achieves enhanced growth inhibition (2.5-14-fold; <0.02 mu M < GI50 < 0.15 mu M) in breast cancer cells; AFt-JAa treatment results in significantly reduced clonal survival, more profound cell cycle perturbation including G2/M arrest, greater reduction in cell numbers, and increased apoptosis compared to the naked agent (p < 0.01). Decreased PLK1 and Mcl-1 expression, together with the appearance of cleaved poly (ADP-ribose)polymerase, corroborate the augmented potency of AFt-JAa. Hence, we demonstrate that AFt represents a biocompatible vehicle for targeted delivery of JAa, offering potential to minimize toxicity and enhance JAa activity in TfR1-expressing tumors. |
format |
Article |
author |
Abuzaid, Haneen Abdelrazig, Salah Ferreira, Lenny Collins, Hilary M. Kim, Dong-Hyun Lim, Kuan-Hon Kam, Toh-Seok Turyanska, Lyudmila Bradshaw, Tracey D. |
author_facet |
Abuzaid, Haneen Abdelrazig, Salah Ferreira, Lenny Collins, Hilary M. Kim, Dong-Hyun Lim, Kuan-Hon Kam, Toh-Seok Turyanska, Lyudmila Bradshaw, Tracey D. |
author_sort |
Abuzaid, Haneen |
title |
Apoferritin-encapsulated jerantinine A for transferrin receptor targeting and enhanced selectivity in breast cancer therapy |
title_short |
Apoferritin-encapsulated jerantinine A for transferrin receptor targeting and enhanced selectivity in breast cancer therapy |
title_full |
Apoferritin-encapsulated jerantinine A for transferrin receptor targeting and enhanced selectivity in breast cancer therapy |
title_fullStr |
Apoferritin-encapsulated jerantinine A for transferrin receptor targeting and enhanced selectivity in breast cancer therapy |
title_full_unstemmed |
Apoferritin-encapsulated jerantinine A for transferrin receptor targeting and enhanced selectivity in breast cancer therapy |
title_sort |
apoferritin-encapsulated jerantinine a for transferrin receptor targeting and enhanced selectivity in breast cancer therapy |
publisher |
American Chemical Society |
publishDate |
2022 |
url |
http://eprints.um.edu.my/41924/ |
_version_ |
1781704571612037120 |
score |
13.188404 |